Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xin-Rong Yang

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transitionKai Zhu, Zhi Dai, Qi Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2017
Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular CarcinomaYun-Fan Sun, Wei Guo, Yang Xu, et al.
Carcinogenesis|May 15, 2013
MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expressionKai Zhu, Qi Pan, Xin Zhang, et al.
Cell Death & Disease|October 23, 2020
BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activityWen-Jing Yang, Yun-Fan Sun, An-Li Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgeryXin-Rong Yang, Yang Xu, Bin Yu, et al.
Journal of Hepatology|March 22, 2017
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinomaAo Huang, Xin Zhao, Xin-Rong Yang, et al.
BMC Cancer|May 11, 2018
PDXliver: a database of liver cancer patient derived xenograft mouse modelsSheng He, Bo Hu, Chao Li, et al.
Annals of Surgical Oncology|April 8, 2018
Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular CarcinomaXiao-Lu Ma, Mi Jiang, Ying Zhao, et al.
Journal of Hematology & Oncology|April 12, 2019
CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosisXiao-Lu Ma, Min-Na Shen, Bo Hu, et al.
Molecular Oncology|December 10, 2020
Circulating tumor cell detection and single-cell analysis using an integrated workflow based on ChimeraX<sup>®</sup> -i120 Platform: A prospective studyPeng-Xiang Wang, Yun-Fan Sun, Wei-Xiang Jin, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transitionKai Zhu, Zhi Dai, Qi Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2017
Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular CarcinomaYun-Fan Sun, Wei Guo, Yang Xu, et al.
Carcinogenesis|May 15, 2013
MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expressionKai Zhu, Qi Pan, Xin Zhang, et al.
Cell Death & Disease|October 23, 2020
BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activityWen-Jing Yang, Yun-Fan Sun, An-Li Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgeryXin-Rong Yang, Yang Xu, Bin Yu, et al.
Journal of Hepatology|March 22, 2017
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinomaAo Huang, Xin Zhao, Xin-Rong Yang, et al.
BMC Cancer|May 11, 2018
PDXliver: a database of liver cancer patient derived xenograft mouse modelsSheng He, Bo Hu, Chao Li, et al.
Annals of Surgical Oncology|April 8, 2018
Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular CarcinomaXiao-Lu Ma, Mi Jiang, Ying Zhao, et al.
Journal of Hematology & Oncology|April 12, 2019
CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosisXiao-Lu Ma, Min-Na Shen, Bo Hu, et al.
Molecular Oncology|December 10, 2020
Circulating tumor cell detection and single-cell analysis using an integrated workflow based on ChimeraX<sup>®</sup> -i120 Platform: A prospective studyPeng-Xiang Wang, Yun-Fan Sun, Wei-Xiang Jin, et al.
Pageof 12